Rapid screening for anxiety and depression in children, teens, and young adults treated for cancer
Official title: Validation of a Rapid Screening Tool for Anxiety-depressive Disorders in Children, Adolescents and Young Adults Treated in Oncology. Multicenter Study. Short Title: HARMONY-Tool
Run by Centre Hospitalier Universitaire de Saint Etienne · NCT07117058 · Data updated 2026-11-12
This study tests a short questionnaire to quickly find anxiety or depression in children, adolescents, and young adults who were treated for cancer.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 7 Years to 25 Years |
| Sex | All |
| Enrollment | 545 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne Academic / other |
| Locations | 7 sites (Angers and 6 other locations) |
| Status | Recruiting |
| Started | March 18, 2025 |
| Main results expected | September 2027 |
| Study ends | September 2027 |
| Registry record updated | July 31, 2026 |
| Trial ID | NCT07117058 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people diagnosed with cancer before age 18 who are in complete remission, at least three months after intensive treatment, and able to give consent (or whose guardians can consent for minors).
✕Probably not a fit
Patients with active relapse or progression, those unable or unwilling to give informed consent, pregnant or breastfeeding women, and adults under legal protection are excluded and unlikely to benefit from this screening.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The HARMONY-Tool project is a multicenter observational effort in France to develop and validate a brief screening questionnaire for anxiety-depressive disorders in survivors of childhood cancer using psychometric methods. Eligible participants (diagnosed before age 18 and at least three months after intensive treatment) will complete the new rapid tool alongside established instruments (SCARED-R-51 and HADS). Researchers will analyze reliability, sensitivity, specificity, and optimal cutoffs to determine how well the short instrument identifies cases needing more assessment. The goal is a practical, quick tool oncologists can use routinely during follow-up visits to flag survivors with possible anxiety or depression.
Why it matters
Potential benefit: If successful, the tool could help oncologists quickly identify survivors who need further psychological care during routine follow-up.
How similar studies have gone: Validated instruments such as SCARED-R-51 and HADS have been used to detect anxiety and depression and prior French work has shown high anxiety rates in childhood cancer survivors, but applying and validating a very brief routine screening tool is a more novel effort.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Patients diagnosed with pediatric cancer before the age of 18, * Patient whose intensive treatment had ended at least 3 months prior to inclusion, * Patients considered to be in complete remission by the doctor responsible for their treatment, * Patient affiliated to or entitled under a social security scheme, * Patient having received informed information about the study OR the holder(s) of parental authority having received informed information about the study in the case of minors. Exclusion Criteria * Refusal to participate expressed by the patient or minor, * Patients whose cancer has relapsed or progressed, * Pregnant women, women in labor, breast-feeding mothers, * Persons deprived of their liberty, hospitalized without consent, hospitalized for purposes other than those of the research, * Adults under legal protection (guardianship) or unable to express their consent.
Where it's running
-
CHU Angers
Angers, France Recruiting -
IHOPe
Lyon, France Recruiting -
CENTRE HOSPITALIER UNIVERSAIRE DE NICE - Hôpital Archet 2
Nice, France Recruiting -
CHU de Saint-Etienne
Saint-Etienne, France Recruiting -
Centre Hospitalier Universitaire Caen Normandie
Caen, France Not yet recruiting -
Centre Hospitalier Universitaire
Grenoble, France Not yet recruiting
Show 1 more location
-
Centre Hospitalier Universitaire
Rouen, France Not yet recruiting
Study contacts
- Principal investigator: Claire Berger, Md — Centre Hospitalier Universitaire de Saint Etienne
- Study coordinator: Claire Berger, Md
- Email: claire.berger@chu-st-etienne.fr
- Phone: (0)4.77.12.79.37
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Neural links for real-world emotions in mood and anxiety
Researchers are testing how real-life emotional moments relate to brain activity and stress responses in young adults with mood and anxiety symptoms, using smartphones, self-reports, tasks, and MRI.
-
Feasibility of Remote Saliva and Sleep Monitoring for ALL Survivors
This study tests whether collecting saliva, blood, hair, and nail samples, along with sleep tracking and surveys, is practical and acceptable for childhood ALL survivors and their siblings.
-
AI-enhanced imagery rescripting for anxiety tied to critical childhood memories
This trial will test whether AI-generated personalized scripts that guide imagery rescripting help adults aged 18–35 with elevated generalized anxiety reduce emotional and physiological reactions to critical childhood memories.
-
Music to improve health and coping for older adults in rural long-term care
This project will try a 6-week music program with active activities like drumming to see if it reduces stress, anxiety, depression, and pain and helps adults living in two Flagstaff long-term care facilities cope better.
-
Screening and brief counseling for substance use in adult survivors of childhood cancer
This study tests whether a short, evidence-based substance-use screening plus a brief counseling session can be added into routine survivorship care for adult survivors of childhood cancer at St. Jude.
-
Helping children and teens manage severe irritability, anxiety, and depression.
This program will try cognitive behavioral therapy plus detailed behavioral and brain tests to see if it helps children and teens (ages 4–17) with severe irritability, anxiety, or depression.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.